Cardiovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years old and = 3 points; 5. I have basic understanding, communication, and written expression abilities; 6. Willing to participate in the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. History of metabolic diseases: including abnormal glucose metabolism: type 1 diabetes; Abnormal lipid metabolism: obesity, anorexia; Abnormal calcium and phosphorus metabolism: hypercalcemia, hypocalcemia, hyperthyroidism, hypothyroidism, hyperparathyroidism, hypoparathyroidism, parathyroid adenoma; Abnormal bone metabolism: osteoporosis, osteomalacia, and bone malnutrition; 2. Taking drugs that affect metabolism or cause weight loss or alter appetite: Modafenib capsules, Bifidobacterium triple active bacteria capsules, Orlistat capsules, Liraglutide injection, phenformin tablets, compound digestive enzyme capsules; 3. Individuals with a life expectancy of <= 6 months for serious illnesses and cancer patients; 4. Pregnant and lactating women; 5. Participated in other clinical trials within 30 days; 6. The researchers believe that the subjects have other important diseases that are not suitable for participation in this study; 7. Refuse to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NUTRIC score; | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS2002 score;Hemoglobin concentration;prealbumin;Skeletal muscle content; | — |
Countries
China
Contacts
National Cardiovascular Center, Fuwai Hospital, Chinese Academy of Medical Sciences